Loading…

Haemonetics agreed to sell its Fajardo, Puerto Rico manufacturing operations to GVS, S.p.A. GVS will acquire manufacturing equipment, inventory and a sublease, while Haemonetics retains IP rights to blood filters. The parties will also enter a long-term supply agreement. Closing expected in Q2 2020.
“Haemonetics Corporation today announced that it has entered into a definitive agreement to sell its Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.